BIOMAT Database Logo BIOMAT Database Logo

[Experimental demonstration of the simulating action of biguanides (phenformin, metformin) on insulin secretion]. 1971

A Loubatières, and M M Mariani, and F Jallet

UI MeSH Term Description Entries
D007003 Hypoglycemia A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH. Fasting Hypoglycemia,Postabsorptive Hypoglycemia,Postprandial Hypoglycemia,Reactive Hypoglycemia,Hypoglycemia, Fasting,Hypoglycemia, Postabsorptive,Hypoglycemia, Postprandial,Hypoglycemia, Reactive
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008687 Metformin A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) Dimethylguanylguanidine,Dimethylbiguanidine,Glucophage,Metformin HCl,Metformin Hydrochloride,HCl, Metformin,Hydrochloride, Metformin
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D010629 Phenformin A biguanide hypoglycemic agent with actions and uses similar to those of METFORMIN. Although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) Fenformin,Phenylethylbiguanide
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin

Related Publications

A Loubatières, and M M Mariani, and F Jallet
[Differences between 2 antidiabetic biguanides: metformin and phenformin].
January 1972, Journees annuelles de diabetologie de l'Hotel-Dieu,
A Loubatières, and M M Mariani, and F Jallet
[Biguanides and glucidic homeostasis: effects of metformin and phenformin on the intermediate metabolism and insulin receptors of normal subjects].
March 1985, Recenti progressi in medicina,
A Loubatières, and M M Mariani, and F Jallet
Phenformin and insulin secretion.
May 1969, Postgraduate medical journal,
A Loubatières, and M M Mariani, and F Jallet
Modern approach to metabolic rehabilitation of cancer patients: biguanides (phenformin and metformin) and beyond.
August 2010, Future oncology (London, England),
A Loubatières, and M M Mariani, and F Jallet
Experimental studies on the mode of action of biguanides.
April 1963, Metabolism: clinical and experimental,
A Loubatières, and M M Mariani, and F Jallet
The hyperlactatemic effect of biguanides: a comparison between phenformin and metformin during a 6-month treatment.
February 1989, Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques,
A Loubatières, and M M Mariani, and F Jallet
[Biguanides in the treatment of obesity. I. Controlled clinical research with placebo, anorectics, phenformin and metformin].
January 1968, Acta diabetologica latina,
A Loubatières, and M M Mariani, and F Jallet
[Demonstration of the mechanism of action of biguanides (author's transl)].
January 1973, Acta diabetologica latina,
A Loubatières, and M M Mariani, and F Jallet
The effect of phenformin on amino acid-induced insulin secretion in diabetics.
April 1975, Diabetologia,
A Loubatières, and M M Mariani, and F Jallet
[Disturbance of intestinal absorption following metformin therapy (observations on the mode of action of biguanides].
December 1969, Diabetologia,
Copied contents to your clipboard!